Contact Details

  • Developing new antibiotics and discovering new targets for antimicrobial therapies
  • Understanding the innate immune response to antibiotic resistant Staphylococcus aureus and how treatment using glycopeptide antibiotics influence this response

Dr Jennifer Payne is an EMBL Australia research fellow in the Cryle Group in the Victorian Node, based in the Department of Biochemistry and Molecular Biology at Monash University. 

Jennifer completed her PhD with Prof Marilyn Anderson at La Trobe University, Melbourne Australia where her passion for host defence peptides began with discovering the mechanism of action of plant defensins and their interaction with cell surfaces. Her PhD thesis was is the top 4% of thesis and awarded the Nancy Millis Medal in 2016.

Shifting into the antibiotic field Jennifer now works on glycopeptide antibiotics in the lab of A/Prof Max Cryle at Monash University and EMBL Australia. Her work on creating a new evolution of antibiotics to combat drug resistant superbugs that harness and modulate the innate immune system has resulted in her being awarded both a 2018 Hugh Roger's fellow and funding as a 2018 VESKI Victorian fellow to spend 6 months working with collaborators at Harvard University in the USA.